Invasive Disease vs Urinary Antigen-Confirmed Pneumococcal Community-Acquired Pneumonia

Published:January 14, 2017DOI:


      The burden of pneumococcal disease is measured only through patients with invasive pneumococcal disease. The urinary antigen test (UAT) for pneumococcus has exhibited high sensitivity and specificity. We aimed to compare the pneumococcal pneumonias diagnosed as invasive disease with pneumococcal pneumonias defined by UAT results.


      A prospective observational study of consecutive nonimmunosuppressed patients with community-acquired pneumonia was performed from January 2000 to December 2014. Patients were stratified into two groups: invasive pneumococcal pneumonia (IPP) defined as a positive blood culture or pleural fluid culture result and noninvasive pneumococcal pneumonia (NIPP) defined as a positive UAT result with negative blood or pleural fluid culture result.


      We analyzed 779 patients (15%) of 5,132, where 361 (46%) had IPP and 418 (54%) had NIPP. Compared with the patients with IPP, those with NIPP presented more frequent chronic pulmonary disease and received previous antibiotics more frequently. Patients with IPP presented more severe community-acquired pneumonia, higher levels of inflammatory markers, and worse oxygenation at admission; more pulmonary complications; greater extrapulmonary complications; longer time to clinical stability; and longer length of hospital stay compared with the NIPP group. Age, chronic liver disease, mechanical ventilation, and acute renal failure were independent risk factors for 30-day crude mortality. Neither IPP nor NIPP was an independent risk factor for 30-day mortality.


      A high percentage of confirmed pneumococcal pneumonia is diagnosed by UAT. Despite differences in clinical characteristics and outcomes, IPP is not an independent risk factor for 30-day mortality compared with NIPP, reinforcing the importance of NIPP for pneumococcal pneumonia.

      Key Words


      ATS/IDSA ( American Thoracic Society/Infectious Diseases Society of America), CAP ( community-acquired pneumonia), IPP ( invasive pneumococcal pneumonia), NIPP ( noninvasive pneumococcal pneumonia), UAT ( urinary antigen test)
      To read this article in full you will need to make a payment
      Subscribe to CHEST
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Welte T.
        • Torres A.
        • Nathwani D.
        Clinical and economic burden of community-acquired pneumonia among adults in Europe.
        Thorax. 2012; 67: 71-79
        • Mandell L.A.
        • Wunderink R.G.
        • Anzueto A.
        • et al.
        Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults.
        Clin Infect Dis. 2007; 44: S27-S72
        • Cillóniz C.
        • Polverino E.
        • Ewig S.
        • et al.
        Impact of age and comorbidity on cause and outcome in community-acquired pneumonia.
        Chest. 2013; 144: 999-1007
        • Said M.A.
        • Johnson H.L.
        • Nonyane B.A.S.
        • et al.
        Estimating the burden of pneumococcal pneumonia among adults: a systematic review and meta-analysis of diagnostic techniques.
        PLoS One. 2013; 8: e60273
        • Cillóniz C.
        • Ewig S.
        • Polverino E.
        • et al.
        Microbial aetiology of community-acquired pneumonia and its relation to severity.
        Thorax. 2011; 66: 340-346
        • Luna C.M.
        • Famiglietti A.
        • Absi R.
        • et al.
        Community-acquired pneumonia: etiology, epidemiology, and outcome at a teaching hospital in Argentina.
        Chest. 2000; 118: 1344-1354
        • Song J.Y.
        • Eun B.W.
        • Nahm M.H.
        Diagnosis of pneumococcal pneumonia: current pitfalls and the way forward.
        Infect Chemother. 2013; 45: 351-366
        • Molinos L.
        • Zalacain R.
        • Menéndez R.
        • et al.
        Sensitivity, specificity, and positivity predictors of the pneumococcal urinary antigen test in community-acquired pneumonia.
        Ann Am Thorac Soc. 2015; 12: 1482-1489
        • Marcos M.A.
        • Jiménez de Anta M.T.
        • de la Bellacasa J.P.
        • et al.
        Rapid urinary antigen test for diagnosis of pneumococcal community-acquired pneumonia in adults.
        Eur Respir J. 2003; 21: 209-214
        • Polverino E.
        • Dambrava P.
        • Cillóniz C.
        • et al.
        Nursing home-acquired pneumonia: a 10 year single-centre experience.
        Thorax. 2010; 65: 354-359
        • Centers for Disease Control and Prevention (CDC)
        Revised surveillance case definition for HIV infection: United States, 2014.
        MMWR Recomm Rep. 2014; 63: 1-10
        • Fine M.J.
        • Auble T.E.
        • Yealy D.M.
        • et al.
        A prediction rule to identify low-risk patients with community-acquired pneumonia.
        N Engl J Med. 1997; 336: 243-250
        • Lim W.S.
        • van der Eerden M.M.
        • Laing R.
        • et al.
        Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study.
        Thorax. 2003; 58: 377-382
        • Feldman C.
        • Alanee S.
        • Yu V.L.
        • et al.
        Severity of illness scoring systems in patients with bacteraemic pneumococcal pneumonia: implications for the intensive care unit care.
        Clin Microbiol Infect. 2009; 15: 850-857
        • Menéndez R.
        • Torres A.
        • Aspa J.
        • et al.
        [Community acquired pneumonia: new guidelines of the Spanish Society of Chest Diseases and Thoracic Surgery (SEPAR)].
        Arch Bronconeumol. 2010; 46 ([article in Spanish]): 543-558
        • Cillóniz C.
        • Ewig S.
        • Polverino E.
        • et al.
        Pulmonary complications of pneumococcal community-acquired pneumonia: incidence, predictors, and outcomes.
        Clin Microbiol Infect. 2012; 18: 1134-1142
        • Hosmer D.W.
        • Lemeshow S.
        Applied Logistic Regression.
        Wiley, New York1989
        • Efron B.
        • Tibshirani R.J.
        An Introduction to the Bootstrap.
        CRC Press, Boca Raton, FL1994
        • Jain S.
        • Self W.H.
        • Wunderink R.G.
        • CDC EPIC Study Team
        Community-acquired pneumonia requiring hospitalization.
        N Engl J Med. 2015; 373: 2382
        • Bonten M.J.
        • Huijts S.M.
        • Bolkenbaas M.
        • CAPITA Coauthors
        Vaccine against pneumococcal pneumonia in adults.
        N Engl J Med. 2015; 373: 93
        • Zalacain R.
        • Capelastegui A.
        • Ruiz L.A.
        • et al.
        Streptococcus pneumoniae antigen in urine: diagnostic usefulness and impact on outcome of bacteraemic pneumococcal pneumonia in a large series of adult patients.
        Respirology. 2014; 19: 936-943
        • van Mens S.P.
        • van Deursen A.M.
        • de Greeff S.C.
        • et al.
        Bacteraemic and non-bacteraemic/urinary antigen-positive pneumococcal community-acquired pneumonia compared.
        Eur J Clin Microbiol Infect Dis. 2015; 34: 115-122
        • Capelastegui A.
        • Zalacain R.
        • Bilbao A.
        • et al.
        Pneumococcal pneumonia: differences according to blood culture results.
        BMC Pulm Med. 2014; 14: 128
        • Andreo F.
        • Ruiz-Manzano J.
        • Prat C.
        • et al.
        Utility of pneumococcal urinary antigen detection in diagnosing exacerbations in COPD patients.
        Respir Med. 2010; 104: 397-403
        • Murdoch D.R.
        • Laing R.T.
        • Cook J.M.
        The NOW S. pneumoniae urinary antigen test positivity rate 6 weeks after pneumonia onset and among patients with COPD.
        Clin Infect Dis. 2003; 37: 153-154
        • Andreo F.
        • Prat C.
        • Ruiz-Manzano J.
        • et al.
        Persistence of Streptococcus pneumoniae urinary antigen excretion after pneumococcal pneumonia.
        Eur J Clin Microbiol Infect Dis. 2009; 28: 197-201
        • Vázquez E.G.
        • Marcos M.A.
        • Vilella A.
        • Yagüe J.
        • Bayas J.M.
        • Mensa J.
        Assessment of a commercial rapid urinary antigen test to detect Streptococcus pneumoniae in patients who received 23-valent pneumococcal polysaccharide vaccine.
        Eur J Clin Microbiol Infect Dis. 2004; 23: 927-929
        • Priner M.
        • Cornillon C.
        • Forestier D.
        • Valero S.
        • Paccalin M.
        Might Streptococcus pneumoniae urinary antigen test be positive because of pneumococcal vaccine?.
        J Am Geriatr Soc. 2008; 56 ([letter to the editor]): 170-171
        • Reed W.W.
        • Byrd G.S.
        • Gates R.H.
        • Howard R.S.
        • Weaver M.J.
        Sputum Gram’s stain in community-acquired pneumococcal pneumonia: a meta-analysis.
        West J Med. 1996; 165: 197-204
        • Musher D.M.
        • Montoya R.
        • Wanahita A.
        Diagnostic value of microscopic examination of Gram-stained sputum and sputum cultures in patients with bacteremic pneumococcal pneumonia.
        Clin Infect Dis. 2004; 39: 165-169
        • García-Vázquez E.
        • Marcos M.A.
        • Mensa J.
        • et al.
        Assessment of the usefulness of sputum culture for diagnosis of community-acquired pneumonia using the PORT predictive scoring system.
        Arch Intern Med. 2004; 164: 1807-1811
        • Albrich W.C.
        • Madhi S.A.
        • Adrian P.V.
        • et al.
        Use of a rapid test of pneumococcal colonization density to diagnose pneumococcal pneumonia.
        Clin Infect Dis. 2012; 54: 601-609